New targets for the treatment of follicular lymphoma |
| |
Authors: | Nishant Tageja Subhash Padheye Prasad Dandawate Ayad Al-Katib Ramzi M Mohammad |
| |
Institution: | 1. Department of Internal Medicine, Wayne State University School of Medicine, Detroit, MI-48201, USA 2. Drug design and Molecular Medicine Research group, Department of Chemistry, D.Y. Patil University, Pune, India 3. Department of Internal Medicine, Division of Hematology/Oncology, Wayne State University School of Medicine, Detroit, Michigan, USA
|
| |
Abstract: | The last two decades have witnessed striking advances in our understanding of the biological factors underlying the development of Follicular lymphoma (FL). Development of newer treatment approaches have improved the outlook for many individuals with these disorders; however, with these advances come new questions. Given the long-term survival of patients with FL, drugs with favourable side-effect profile and minimal long-term risks are desired. FL is incurable with current treatment modalities. It often runs an indolent course with multiple relapses and progressively shorter intervals of remission. The identification of new targets and development of novel targeted therapies is imperative to exploit the biology of FL while inherently preventing relapse and prolonging survival. This review summarizes the growing body of knowledge regarding novel therapeutic targets, enabling the concept of individualized targeted therapy for the treatment of FL. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|